INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAB4 Class: CONV BD US

CONTRARIAN CAPITAL MANAGEMENT, L.L.C.'s Holding History (CIK: 0001050417)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 30,300,000 Value ($000) $20,093 Avg Close — Range —
Q1 2021
Shares 11,550,000 Value ($000) $7,487 Avg Close — Range —